Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Marco Del Chiaro

Concepts (574)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pancreatic Neoplasms
161
2025
875
32.550
Why?
Pancreatectomy
69
2025
241
16.940
Why?
Carcinoma, Pancreatic Ductal
67
2025
269
16.510
Why?
Pancreaticoduodenectomy
32
2025
158
6.920
Why?
Adenocarcinoma
28
2025
889
6.370
Why?
Neoadjuvant Therapy
28
2025
378
5.530
Why?
Pancreas
38
2024
304
4.400
Why?
Adenocarcinoma, Mucinous
16
2024
73
3.810
Why?
Mesenteric Veins
7
2025
18
3.120
Why?
Pancreatic Cyst
11
2024
51
2.750
Why?
Antineoplastic Combined Chemotherapy Protocols
17
2025
1559
2.340
Why?
Pancreatic Fistula
11
2023
27
2.250
Why?
Portal Vein
11
2025
108
2.240
Why?
Ampulla of Vater
7
2025
39
2.130
Why?
Common Bile Duct Neoplasms
6
2025
27
2.090
Why?
Carcinoma, Papillary
9
2021
76
2.010
Why?
Retrospective Studies
88
2025
14532
1.870
Why?
Pancreatic Ducts
10
2022
79
1.860
Why?
Humans
238
2025
129527
1.850
Why?
CA-19-9 Antigen
4
2024
22
1.770
Why?
Aged
86
2025
22063
1.720
Why?
Exocrine Pancreatic Insufficiency
5
2019
20
1.620
Why?
Prognosis
30
2025
3772
1.610
Why?
Survival Rate
22
2025
1870
1.530
Why?
Early Detection of Cancer
6
2021
371
1.520
Why?
Middle Aged
93
2025
31087
1.460
Why?
Neoplasm Recurrence, Local
6
2024
956
1.440
Why?
Gastrointestinal Neoplasms
2
2023
72
1.410
Why?
Vascular Surgical Procedures
4
2025
295
1.350
Why?
Mesenteric Artery, Superior
4
2020
15
1.330
Why?
Pancreas Transplantation
24
2010
75
1.320
Why?
Postoperative Complications
30
2025
2475
1.230
Why?
Male
109
2025
63586
1.190
Why?
Aged, 80 and over
43
2025
7052
1.190
Why?
Pancreatitis, Chronic
6
2020
51
1.160
Why?
Treatment Outcome
40
2025
10232
1.090
Why?
Female
105
2025
68650
1.070
Why?
Quality of Life
8
2025
2694
1.070
Why?
Islets of Langerhans
5
2020
790
1.010
Why?
Carcinoma, Neuroendocrine
2
2023
32
1.000
Why?
Chemotherapy, Adjuvant
13
2025
376
0.990
Why?
Liver Neoplasms
4
2024
635
0.990
Why?
Endosonography
5
2021
141
0.980
Why?
Biomarkers, Tumor
13
2024
1159
0.940
Why?
Databases, Factual
3
2024
1261
0.930
Why?
Nomograms
3
2022
47
0.930
Why?
Precancerous Conditions
3
2015
160
0.920
Why?
Follow-Up Studies
23
2024
4891
0.890
Why?
Adult
70
2025
35505
0.890
Why?
Hepatoblastoma
1
2024
42
0.880
Why?
Duodenal Neoplasms
3
2023
21
0.870
Why?
Neoplasms, Cystic, Mucinous, and Serous
3
2023
25
0.860
Why?
Thrombelastography
2
2024
150
0.850
Why?
Minimally Invasive Surgical Procedures
3
2020
175
0.780
Why?
Risk Assessment
11
2025
3255
0.720
Why?
Surgical Stapling
1
2021
14
0.720
Why?
Absorbable Implants
1
2021
35
0.710
Why?
Fluorouracil
10
2025
197
0.710
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2022
197
0.700
Why?
Organ Transplantation
2
2023
228
0.690
Why?
Neoplasm Staging
12
2024
1281
0.690
Why?
Cystadenocarcinoma, Mucinous
2
2018
14
0.680
Why?
Neoplasms, Second Primary
2
2019
106
0.680
Why?
Leucovorin
7
2025
70
0.670
Why?
Neoplasm Invasiveness
7
2020
481
0.670
Why?
Sweden
6
2025
93
0.670
Why?
Vascular Neoplasms
1
2020
17
0.660
Why?
Neoplasms, Multiple Primary
3
2015
55
0.660
Why?
Arteries
2
2019
266
0.650
Why?
Pancreatitis
5
2022
124
0.650
Why?
Liver Transplantation
4
2024
833
0.640
Why?
Adenocarcinoma, Papillary
2
2017
11
0.640
Why?
Endocrine System Diseases
1
2019
33
0.630
Why?
Practice Guidelines as Topic
4
2024
1510
0.630
Why?
Neuroendocrine Tumors
4
2023
99
0.610
Why?
Cohort Studies
12
2024
5423
0.580
Why?
Europe
8
2021
362
0.550
Why?
Patient Compliance
1
2021
567
0.550
Why?
Evidence-Based Medicine
5
2024
715
0.550
Why?
Metabolomics
2
2019
652
0.540
Why?
Patient Selection
9
2024
659
0.540
Why?
Kidney Transplantation
17
2016
669
0.530
Why?
Living Donors
3
2016
286
0.530
Why?
Neoplasm Metastasis
1
2019
609
0.520
Why?
Hepatic Artery
4
2020
58
0.520
Why?
Celiac Artery
4
2020
10
0.520
Why?
Watchful Waiting
1
2016
67
0.520
Why?
Hepatitis B virus
1
2016
36
0.500
Why?
Pancreaticojejunostomy
3
2022
8
0.500
Why?
Prospective Studies
15
2024
7150
0.490
Why?
Hypothermia, Induced
1
2016
76
0.480
Why?
Disease Progression
5
2022
2628
0.460
Why?
Organ Sparing Treatments
1
2015
32
0.460
Why?
Survival Analysis
12
2024
1270
0.460
Why?
Pancreatic Diseases
3
2020
71
0.460
Why?
Adenoma
3
2025
211
0.450
Why?
Antineoplastic Agents
6
2021
2044
0.440
Why?
Risk Factors
16
2024
9779
0.430
Why?
Deoxycytidine
8
2025
163
0.430
Why?
Clinical Trials as Topic
1
2018
1001
0.430
Why?
Carcinoma, Hepatocellular
1
2016
270
0.430
Why?
Japan
5
2025
98
0.420
Why?
Palliative Care
3
2019
704
0.420
Why?
Radiotherapy, Adjuvant
2
2024
208
0.420
Why?
Cholangiopancreatography, Endoscopic Retrograde
4
2019
206
0.420
Why?
Combined Modality Therapy
5
2024
1201
0.410
Why?
Cystadenocarcinoma
1
2013
2
0.410
Why?
Cystadenoma
1
2013
3
0.410
Why?
Stomach Neoplasms
2
2024
97
0.400
Why?
Robotics
1
2014
92
0.400
Why?
Tomography, X-Ray Computed
10
2021
2503
0.400
Why?
Autoimmune Diseases
3
2021
428
0.390
Why?
Cystadenoma, Serous
3
2020
18
0.390
Why?
Diabetes Mellitus
3
2019
988
0.390
Why?
Italy
11
2013
98
0.390
Why?
Incidence
8
2019
2643
0.380
Why?
Diagnosis, Differential
8
2022
1422
0.370
Why?
Peritoneal Neoplasms
2
2024
86
0.370
Why?
Dilatation, Pathologic
3
2020
60
0.370
Why?
Propensity Score
3
2025
266
0.360
Why?
Gastroenterology
2
2023
177
0.350
Why?
Risk
5
2022
857
0.350
Why?
Gamma Rays
2
2021
54
0.340
Why?
Magnetic Resonance Imaging
8
2021
3392
0.340
Why?
Neoplastic Syndromes, Hereditary
1
2010
37
0.330
Why?
Chemoradiotherapy
2
2022
208
0.330
Why?
Portal System
6
2020
13
0.330
Why?
Tissue Donors
14
2005
391
0.330
Why?
Microbiota
3
2025
734
0.330
Why?
Adolescent
15
2022
20409
0.320
Why?
Neoplasm Grading
4
2020
283
0.320
Why?
Decision Making
1
2016
860
0.310
Why?
Kidney
2
2016
1382
0.310
Why?
Lymphatic Metastasis
3
2024
319
0.310
Why?
Age Factors
6
2022
3150
0.300
Why?
Population Surveillance
2
2019
440
0.300
Why?
Young Adult
11
2022
12438
0.300
Why?
Benchmarking
2
2020
175
0.300
Why?
Mass Screening
2
2019
1186
0.300
Why?
Tumor Burden
2
2022
287
0.290
Why?
Software
2
2017
608
0.290
Why?
Predictive Value of Tests
5
2024
1950
0.280
Why?
Laparoscopy
3
2021
446
0.280
Why?
Graft Survival
12
2005
514
0.280
Why?
Genetic Predisposition to Disease
6
2019
2271
0.270
Why?
Islets of Langerhans Transplantation
3
2020
63
0.270
Why?
Internationality
4
2020
150
0.270
Why?
Disease-Free Survival
5
2023
647
0.260
Why?
Cytoreduction Surgical Procedures
2
2024
59
0.260
Why?
Family Health
1
2007
198
0.260
Why?
Drainage
10
2022
164
0.260
Why?
Pedigree
3
2014
482
0.260
Why?
Multidetector Computed Tomography
2
2016
33
0.250
Why?
Length of Stay
5
2021
1132
0.250
Why?
Observer Variation
2
2024
314
0.250
Why?
Cholangiocarcinoma
2
2024
77
0.240
Why?
Cyst Fluid
2
2022
25
0.240
Why?
Immunohistochemistry
5
2019
1684
0.240
Why?
Lymphocytes, Tumor-Infiltrating
2
2018
204
0.240
Why?
Proportional Hazards Models
4
2023
1196
0.230
Why?
Mucosal-Associated Invariant T Cells
1
2025
27
0.230
Why?
Pylorus
1
2024
17
0.230
Why?
Chemoradiotherapy, Adjuvant
3
2019
41
0.230
Why?
Gallbladder Neoplasms
1
2024
21
0.230
Why?
Perioperative Care
2
2024
165
0.230
Why?
Spheroids, Cellular
1
2025
76
0.220
Why?
Time Factors
10
2021
6530
0.220
Why?
Prevalence
3
2023
2561
0.210
Why?
Lymph Node Excision
1
2024
164
0.210
Why?
Incidental Findings
2
2021
80
0.210
Why?
Bile Duct Neoplasms
1
2024
99
0.210
Why?
Metastasectomy
1
2023
19
0.210
Why?
Hyperemia
1
2023
48
0.210
Why?
Hospital Mortality
4
2020
851
0.210
Why?
Reoperation
7
2018
542
0.200
Why?
Pilot Projects
5
2023
1594
0.200
Why?
Surgical Oncology
1
2022
22
0.200
Why?
Hyperamylasemia
1
2022
3
0.200
Why?
STAT3 Transcription Factor
2
2022
194
0.190
Why?
Pancreatitis, Acute Necrotizing
1
2022
12
0.190
Why?
Forecasting
1
2023
360
0.190
Why?
Colonic Neoplasms
1
2024
241
0.190
Why?
Carcinoma, Acinar Cell
1
2021
4
0.190
Why?
Plastics
1
2022
47
0.190
Why?
Multicenter Studies as Topic
1
2023
287
0.190
Why?
Angiotensin Receptor Antagonists
1
2022
89
0.180
Why?
Biliary Tract Surgical Procedures
1
2021
25
0.180
Why?
Pathology, Clinical
1
2021
36
0.180
Why?
Datasets as Topic
1
2021
109
0.180
Why?
Cysts
1
2022
108
0.180
Why?
Bacteria
2
2025
812
0.180
Why?
ADAM10 Protein
1
2021
30
0.180
Why?
Surgical Mesh
1
2021
46
0.180
Why?
Fusobacterium nucleatum
1
2020
3
0.170
Why?
Fusobacterium Infections
1
2020
7
0.170
Why?
Netherlands
3
2025
77
0.170
Why?
Digestive System Surgical Procedures
1
2021
98
0.170
Why?
Body Composition
1
2024
649
0.170
Why?
Amyloid Precursor Protein Secretases
1
2021
78
0.170
Why?
Child, Preschool
4
2024
10499
0.170
Why?
Microdissection
2
2011
15
0.170
Why?
Oligonucleotides, Antisense
1
2020
111
0.170
Why?
Antimetabolites, Antineoplastic
2
2010
91
0.170
Why?
Blood
1
2020
105
0.170
Why?
Comorbidity
2
2022
1548
0.160
Why?
Radiation Injuries
1
2021
135
0.160
Why?
Myeloid-Derived Suppressor Cells
1
2020
64
0.160
Why?
Antibodies, Bacterial
1
2020
139
0.160
Why?
Conservative Treatment
1
2020
32
0.160
Why?
Cyclosporine
4
2005
263
0.160
Why?
Cystadenocarcinoma, Serous
1
2020
68
0.160
Why?
Dilatation
1
2019
62
0.160
Why?
Lasers
2
2011
133
0.160
Why?
Elective Surgical Procedures
1
2020
165
0.150
Why?
Biliary Tract Diseases
1
2019
36
0.150
Why?
Epithelial-Mesenchymal Transition
1
2021
201
0.150
Why?
Bacterial Infections
1
2021
234
0.150
Why?
Laparotomy
2
2016
104
0.150
Why?
Saliva
1
2020
212
0.150
Why?
Sensitivity and Specificity
2
2021
1842
0.150
Why?
Bile Ducts
1
2019
68
0.150
Why?
Mouth
1
2019
84
0.150
Why?
Referral and Consultation
1
2024
732
0.150
Why?
Organ Culture Techniques
1
2019
155
0.150
Why?
Patient Care Team
3
2020
600
0.150
Why?
Immunosuppressive Agents
6
2005
858
0.150
Why?
Gene Expression Regulation, Neoplastic
4
2019
1327
0.150
Why?
Insulin
8
2013
2313
0.150
Why?
Nutritional Support
1
2018
32
0.150
Why?
DNA Damage
1
2021
383
0.150
Why?
Fibrosis
1
2021
526
0.150
Why?
Societies, Medical
2
2020
757
0.150
Why?
Iopamidol
2
2016
16
0.150
Why?
Recombinant Fusion Proteins
4
2005
650
0.140
Why?
Patient Acceptance of Health Care
1
2024
761
0.140
Why?
Jejunum
2
2016
30
0.140
Why?
Carcinoma
1
2019
213
0.140
Why?
Radiosurgery
1
2020
321
0.140
Why?
DNA, Bacterial
1
2019
323
0.140
Why?
Kaplan-Meier Estimate
2
2016
850
0.140
Why?
Logistic Models
2
2020
1983
0.140
Why?
Malnutrition
1
2018
79
0.140
Why?
Cross-Sectional Studies
3
2024
5078
0.140
Why?
Biliary Tract Neoplasms
1
2016
25
0.130
Why?
Hepatic Duct, Common
1
2016
6
0.130
Why?
Jaundice, Obstructive
1
2016
2
0.130
Why?
Hyperglycemia
1
2020
325
0.130
Why?
Epitopes
1
2018
473
0.130
Why?
Cholangiopancreatography, Magnetic Resonance
1
2016
16
0.130
Why?
Triiodobenzoic Acids
1
2016
9
0.130
Why?
Organ Preservation Solutions
3
2005
45
0.130
Why?
Cholangitis, Sclerosing
1
2016
71
0.130
Why?
Radiographic Image Enhancement
1
2016
54
0.120
Why?
Sex Factors
1
2022
1966
0.120
Why?
Cannabis
1
2023
461
0.120
Why?
Embolization, Therapeutic
1
2018
207
0.120
Why?
Machine Learning
1
2020
441
0.120
Why?
Printing, Three-Dimensional
1
2016
88
0.120
Why?
Bacteriocins
1
2015
2
0.120
Why?
Pneumonia, Viral
1
2020
342
0.120
Why?
Hepatitis B
1
2016
66
0.120
Why?
Genes, BRCA2
1
2015
22
0.120
Why?
Recovery of Function
1
2019
644
0.120
Why?
Coronavirus Infections
1
2020
336
0.120
Why?
Genes, BRCA1
1
2015
30
0.120
Why?
Organ Preservation
3
2004
94
0.120
Why?
Interferon-gamma
1
2018
773
0.120
Why?
Surveys and Questionnaires
4
2022
5429
0.120
Why?
Diabetes Mellitus, Type 1
10
2010
3622
0.120
Why?
Papilloma, Intraductal
1
2014
3
0.120
Why?
Heredity
1
2014
12
0.120
Why?
Genomics
2
2017
715
0.110
Why?
Membrane Proteins
1
2021
1118
0.110
Why?
Albumins
2
2025
104
0.110
Why?
Germany
2
2024
100
0.110
Why?
Amylases
1
2013
16
0.110
Why?
Risk Adjustment
1
2014
78
0.110
Why?
Neoplasm, Residual
1
2014
121
0.110
Why?
High-Throughput Nucleotide Sequencing
1
2017
486
0.110
Why?
Apoptosis
6
2021
2488
0.110
Why?
Reproducibility of Results
6
2019
3081
0.110
Why?
Antibodies, Monoclonal
4
2005
1366
0.110
Why?
Tissue and Organ Harvesting
5
2005
70
0.110
Why?
Paclitaxel
2
2025
217
0.110
Why?
Perception
1
2016
346
0.110
Why?
Breast Neoplasms
2
2024
2101
0.110
Why?
Severity of Illness Index
3
2019
2734
0.110
Why?
Precision Medicine
1
2017
385
0.110
Why?
Virus Diseases
1
2016
210
0.110
Why?
Abdomen
2
2004
119
0.110
Why?
North America
2
2024
294
0.110
Why?
MicroRNAs
2
2010
677
0.110
Why?
Cell Proliferation
5
2021
2367
0.100
Why?
Tacrolimus
2
2005
193
0.100
Why?
Syndrome
1
2014
338
0.100
Why?
Cystadenoma, Mucinous
1
2013
13
0.100
Why?
Diagnostic Imaging
1
2015
326
0.100
Why?
Imaging, Three-Dimensional
1
2016
530
0.100
Why?
Cadaver
8
2005
308
0.100
Why?
Diagnostic Errors
1
2014
162
0.100
Why?
Immunotherapy, Adoptive
1
2016
300
0.100
Why?
ROC Curve
3
2024
503
0.100
Why?
Neoplasms
2
2022
2450
0.100
Why?
Insulin-Secreting Cells
2
2007
367
0.100
Why?
Endoscopy
1
2014
290
0.100
Why?
Catheter Ablation
1
2015
336
0.090
Why?
Practice Patterns, Physicians'
1
2020
1257
0.090
Why?
Preoperative Care
1
2014
337
0.090
Why?
Receptors, Antigen, T-Cell
1
2016
707
0.090
Why?
C-Reactive Protein
1
2013
400
0.090
Why?
Loss of Heterozygosity
1
2011
45
0.090
Why?
Carcinoma in Situ
1
2011
44
0.090
Why?
Biomarkers
1
2022
3968
0.090
Why?
Graft Rejection
5
2005
598
0.090
Why?
Kruppel-Like Transcription Factors
1
2011
65
0.090
Why?
United States
3
2024
13865
0.090
Why?
Lung Neoplasms
1
2023
2342
0.080
Why?
Raffinose
3
2005
23
0.080
Why?
Tissue and Organ Procurement
2
2004
290
0.080
Why?
Disaccharides
3
2005
18
0.080
Why?
Glucose
3
2020
996
0.080
Why?
Mannitol
3
2005
38
0.080
Why?
Allopurinol
3
2005
62
0.080
Why?
Histidine
3
2005
60
0.080
Why?
Glutamates
3
2005
57
0.080
Why?
Electrolytes
3
2005
58
0.080
Why?
CD8-Positive T-Lymphocytes
1
2016
855
0.080
Why?
Peptides
1
2015
925
0.080
Why?
Quality of Health Care
1
2014
607
0.080
Why?
Lymph Nodes
2
2024
471
0.080
Why?
Duodenum
1
2010
74
0.080
Why?
Cell Line, Tumor
4
2025
3181
0.080
Why?
Tumor Cells, Cultured
2
2021
931
0.080
Why?
Intra-Abdominal Fat
1
2009
88
0.080
Why?
Down-Regulation
1
2011
631
0.070
Why?
Adenosine
3
2005
225
0.070
Why?
T-Lymphocytes, Regulatory
2
2022
372
0.070
Why?
Glutathione
3
2005
349
0.070
Why?
Magnetic Resonance Angiography
1
2010
234
0.070
Why?
Enzyme Replacement Therapy
2
2018
13
0.070
Why?
Germ-Line Mutation
2
2019
140
0.070
Why?
Morbidity
2
2019
300
0.070
Why?
Diabetic Retinopathy
2
2006
179
0.070
Why?
ErbB Receptors
1
2010
605
0.070
Why?
Gliclazide
1
2007
2
0.070
Why?
Clinical Decision-Making
2
2020
304
0.070
Why?
Cytotoxicity, Immunologic
2
2018
220
0.070
Why?
Hepatectomy
2
2024
212
0.060
Why?
Arterial Occlusive Diseases
1
2007
80
0.060
Why?
Consensus
2
2020
622
0.060
Why?
Equilibrative Nucleoside Transporter 1
1
2006
17
0.060
Why?
Child
4
2024
20932
0.060
Why?
Extracorporeal Circulation
1
2006
13
0.060
Why?
Blood Loss, Surgical
1
2007
96
0.060
Why?
C-Peptide
1
2007
155
0.060
Why?
Hepatic Veins
1
2006
31
0.060
Why?
Tumor Microenvironment
2
2020
627
0.060
Why?
Lacerations
1
2006
29
0.060
Why?
Vena Cava, Inferior
1
2006
68
0.060
Why?
Alcohol Drinking
2
2013
764
0.060
Why?
Drug Resistance, Neoplasm
1
2010
751
0.060
Why?
Neovascularization, Pathologic
1
2007
292
0.060
Why?
Transplantation, Autologous
1
2006
213
0.060
Why?
Proto-Oncogene Proteins c-bcl-2
2
2007
232
0.060
Why?
Chemotherapy, Cancer, Regional Perfusion
1
2024
26
0.060
Why?
Smoking
2
2013
1501
0.060
Why?
Abdominal Injuries
1
2006
118
0.060
Why?
Jehovah's Witnesses
1
2004
3
0.060
Why?
Bezoars
1
2004
4
0.060
Why?
Contrast Media
3
2016
393
0.060
Why?
RNA, Messenger
5
2011
2697
0.050
Why?
Anthropometry
1
2024
203
0.050
Why?
Biopsy
3
2019
1087
0.050
Why?
Intestinal Obstruction
1
2004
49
0.050
Why?
Splenectomy
1
2024
58
0.050
Why?
Chemotaxis
1
2004
130
0.050
Why?
Consensus Development Conferences as Topic
1
2023
26
0.050
Why?
Cystectomy
1
2003
37
0.050
Why?
Antioxidants
1
2007
557
0.050
Why?
Intestine, Small
1
2004
151
0.050
Why?
Intraoperative Complications
1
2004
129
0.050
Why?
Postoperative Period
2
2019
329
0.050
Why?
Ileum
1
2003
116
0.050
Why?
Wounds, Nonpenetrating
1
2006
273
0.050
Why?
Delphi Technique
1
2024
227
0.050
Why?
Gastrectomy
1
2023
102
0.050
Why?
Propylamines
1
2022
11
0.050
Why?
Genetic Testing
1
2005
422
0.050
Why?
Carbohydrates
1
2022
64
0.050
Why?
Stents
2
2022
504
0.050
Why?
Azathioprine
1
2001
50
0.050
Why?
Urinary Bladder
1
2003
176
0.050
Why?
Creatinine
4
2004
489
0.050
Why?
Vascular Diseases
1
2004
240
0.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2011
952
0.040
Why?
Necrosis
1
2022
234
0.040
Why?
Mycophenolic Acid
1
2001
110
0.040
Why?
Retroperitoneal Space
3
2005
16
0.040
Why?
Hernia, Inguinal
1
2001
34
0.040
Why?
Steroids
1
2001
158
0.040
Why?
Urinary Bladder Neoplasms
1
2003
225
0.040
Why?
Ephrin-B2
1
2021
50
0.040
Why?
Endometriosis
1
2001
46
0.040
Why?
Endoscopy, Gastrointestinal
1
2023
218
0.040
Why?
Hyperplasia
1
2021
175
0.040
Why?
Case-Control Studies
2
2022
3383
0.040
Why?
Microbial Viability
1
2021
83
0.040
Why?
Medical Oncology
1
2022
267
0.040
Why?
Adipose Tissue
1
2024
594
0.040
Why?
Mice, Inbred C57BL
2
2021
5468
0.040
Why?
Diagnosis, Computer-Assisted
1
2020
86
0.040
Why?
Mice
3
2022
16973
0.040
Why?
Capecitabine
1
2019
45
0.040
Why?
Hematopoietic Stem Cell Transplantation
1
2005
577
0.040
Why?
Secretin
2
2010
4
0.040
Why?
Florida
1
2020
93
0.040
Why?
Margins of Excision
1
2019
38
0.040
Why?
Republic of Korea
1
2019
29
0.040
Why?
Matched-Pair Analysis
1
2019
39
0.040
Why?
Asia
1
2019
58
0.040
Why?
Treatment Failure
3
2005
339
0.040
Why?
International Cooperation
1
2020
177
0.040
Why?
Cell Death
1
2021
352
0.040
Why?
Hyperthermia, Induced
1
2020
108
0.040
Why?
Acute Disease
1
2022
975
0.040
Why?
Area Under Curve
1
2019
306
0.040
Why?
Cells, Cultured
3
2016
4087
0.040
Why?
Aquaporin 1
1
2018
3
0.040
Why?
Radiotherapy
1
2019
185
0.040
Why?
Mice, Nude
1
2020
677
0.040
Why?
Stromal Cells
1
2019
106
0.040
Why?
Pancreatic Elastase
1
2018
60
0.040
Why?
Cause of Death
3
2005
395
0.040
Why?
Congresses as Topic
1
2020
215
0.040
Why?
Xenograft Model Antitumor Assays
1
2021
804
0.040
Why?
Anastomosis, Roux-en-Y
2
2010
27
0.040
Why?
Hospitals, High-Volume
1
2018
39
0.040
Why?
Multivariate Analysis
2
2013
1491
0.040
Why?
Preoperative Period
1
2018
116
0.040
Why?
Anastomotic Leak
1
2017
39
0.030
Why?
Betacoronavirus
1
2020
252
0.030
Why?
Tumor Suppressor Protein p53
2
2017
502
0.030
Why?
Patient Safety
1
2020
287
0.030
Why?
Oligonucleotide Array Sequence Analysis
2
2010
754
0.030
Why?
Robotic Surgical Procedures
1
2019
113
0.030
Why?
Diabetic Nephropathies
3
2005
284
0.030
Why?
Intestinal Neoplasms
1
2016
28
0.030
Why?
Cell Movement
1
2021
942
0.030
Why?
Drug Therapy, Combination
3
2004
1037
0.030
Why?
Principal Component Analysis
1
2016
190
0.030
Why?
Proto-Oncogene Proteins p21(ras)
1
2017
259
0.030
Why?
Transplantation, Homologous
2
2010
402
0.030
Why?
Mass Spectrometry
1
2019
717
0.030
Why?
Nutritional Status
1
2018
328
0.030
Why?
Anastomosis, Surgical
1
2016
150
0.030
Why?
Vitamins
1
2017
173
0.030
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2016
98
0.030
Why?
Research Design
1
2021
1043
0.030
Why?
Feces
1
2018
442
0.030
Why?
Cell Line
1
2021
2774
0.030
Why?
Animals
3
2022
35334
0.030
Why?
Anatomy, Cross-Sectional
1
2014
10
0.030
Why?
Extracellular Matrix
1
2019
506
0.030
Why?
Radiation Dosage
1
2016
154
0.030
Why?
Flow Cytometry
1
2018
1158
0.030
Why?
Intraoperative Care
1
2014
46
0.030
Why?
Kidney Failure, Chronic
3
2004
546
0.030
Why?
Systemic Inflammatory Response Syndrome
1
2014
85
0.030
Why?
Immunologic Memory
1
2016
349
0.030
Why?
Feasibility Studies
1
2017
869
0.030
Why?
Biomedical Research
1
2019
639
0.030
Why?
Dose-Response Relationship, Drug
2
2010
2013
0.030
Why?
Indole Alkaloids
1
2013
7
0.030
Why?
Antigens, Neoplasm
1
2016
308
0.030
Why?
Drug Administration Schedule
2
2005
763
0.030
Why?
Algorithms
1
2020
1614
0.030
Why?
Cytokines
2
2016
2018
0.030
Why?
Drug Interactions
2
2005
397
0.030
Why?
Peptic Ulcer
1
2013
18
0.030
Why?
Histocompatibility Testing
2
2004
121
0.030
Why?
Asymptomatic Diseases
1
2013
84
0.020
Why?
Global Health
1
2015
328
0.020
Why?
Safety
2
2004
335
0.020
Why?
Postoperative Care
1
2013
244
0.020
Why?
Pandemics
1
2020
1500
0.020
Why?
Lymphocyte Activation
1
2016
1109
0.020
Why?
Hypoxia
1
2019
1081
0.020
Why?
Randomized Controlled Trials as Topic
1
2017
1368
0.020
Why?
Carcinoma, Renal Cell
1
2013
177
0.020
Why?
Anti-Bacterial Agents
1
2021
1708
0.020
Why?
In Situ Hybridization
1
2011
296
0.020
Why?
Korea
1
2010
10
0.020
Why?
Cell Growth Processes
1
2010
49
0.020
Why?
Lung
1
2023
3928
0.020
Why?
Matrix Metalloproteinase 2
1
2010
56
0.020
Why?
Microsatellite Repeats
1
2011
163
0.020
Why?
Odds Ratio
1
2013
1018
0.020
Why?
Biopsy, Needle
1
2010
187
0.020
Why?
Matrix Metalloproteinase 9
1
2010
123
0.020
Why?
Cardiovascular Diseases
1
2001
1997
0.020
Why?
Thyroid Neoplasms
1
2013
305
0.020
Why?
Blood Glucose
3
2004
2071
0.020
Why?
Edetic Acid
1
2009
49
0.020
Why?
Pyridoxal Phosphate
1
2009
21
0.020
Why?
Kidney Neoplasms
1
2013
346
0.020
Why?
PTEN Phosphohydrolase
1
2010
157
0.020
Why?
Tetrazolium Salts
1
2008
17
0.020
Why?
Proto-Oncogene Proteins c-akt
1
2010
427
0.020
Why?
Thiazoles
1
2008
118
0.020
Why?
Vascular Endothelial Growth Factor A
1
2010
527
0.020
Why?
Surgical Procedures, Operative
1
2010
242
0.020
Why?
bcl-2-Associated X Protein
1
2007
55
0.020
Why?
Glyburide
1
2007
32
0.020
Why?
Recurrence
1
2010
1011
0.020
Why?
Epigenesis, Genetic
1
2011
617
0.020
Why?
Microscopy, Electron
1
2007
423
0.020
Why?
Deoxycytidine Kinase
1
2006
3
0.020
Why?
Ribonucleoside Diphosphate Reductase
1
2006
5
0.020
Why?
Mutation
1
2017
3702
0.020
Why?
Motorcycles
1
2006
6
0.020
Why?
Choledochostomy
1
2006
11
0.020
Why?
Budd-Chiari Syndrome
1
2006
5
0.020
Why?
Tyrosine
1
2007
222
0.020
Why?
5'-Nucleotidase
1
2006
39
0.020
Why?
Fluorescein Angiography
1
2006
142
0.020
Why?
Cytidine Deaminase
1
2006
57
0.020
Why?
Colorectal Neoplasms
1
2013
744
0.020
Why?
Phosphorylation
1
2010
1714
0.020
Why?
Prostatic Neoplasms
1
2013
995
0.020
Why?
Economics, Pharmaceutical
1
2005
9
0.020
Why?
Antilymphocyte Serum
1
2005
63
0.020
Why?
Hemorrhage
1
2010
680
0.010
Why?
Blood Group Incompatibility
1
2005
11
0.010
Why?
Methylprednisolone
1
2005
83
0.010
Why?
Fatal Outcome
1
2006
300
0.010
Why?
Maximum Tolerated Dose
1
2005
193
0.010
Why?
Proteomics
1
2011
1053
0.010
Why?
Isoantibodies
1
2005
57
0.010
Why?
Accidents, Traffic
1
2006
184
0.010
Why?
Glycerolphosphate Dehydrogenase
1
2004
6
0.010
Why?
Fructose-Bisphosphate Aldolase
1
2004
8
0.010
Why?
Glucokinase
1
2004
14
0.010
Why?
Intraocular Pressure
1
2006
299
0.010
Why?
DNA Primers
1
2005
507
0.010
Why?
Visual Acuity
1
2006
326
0.010
Why?
Pyruvate Kinase
1
2004
26
0.010
Why?
Renal Circulation
1
2004
57
0.010
Why?
Diabetic Neuropathies
1
2005
94
0.010
Why?
Tissue Culture Techniques
1
2004
75
0.010
Why?
Transcriptional Activation
1
2006
366
0.010
Why?
Pharmacogenetics
1
2005
172
0.010
Why?
Tumor Suppressor Proteins
1
2006
311
0.010
Why?
Carcinoma, Transitional Cell
1
2003
59
0.010
Why?
Monitoring, Physiologic
1
2005
261
0.010
Why?
Kidney Function Tests
1
2003
152
0.010
Why?
Cell Separation
1
2004
315
0.010
Why?
Respiratory Insufficiency
1
2006
312
0.010
Why?
In Vitro Techniques
1
2004
1091
0.010
Why?
Thrombosis
1
2005
348
0.010
Why?
Base Sequence
1
2005
2138
0.010
Why?
Obesity, Morbid
1
2005
242
0.010
Why?
Vulvar Diseases
1
2001
9
0.010
Why?
Immunoenzyme Techniques
1
2001
211
0.010
Why?
Gene Expression
1
2006
1461
0.010
Why?
Glucocorticoids
1
2005
583
0.010
Why?
Ischemia
1
2004
405
0.010
Why?
Morphogenesis
1
2001
158
0.010
Why?
Hemodynamics
1
2004
1094
0.010
Why?
Neoplasm Proteins
1
2001
417
0.010
Why?
Blood Pressure
1
2005
1735
0.010
Why?
T-Lymphocytes
1
2005
1935
0.010
Why?
Hypoglycemic Agents
1
2005
1219
0.010
Why?
Body Mass Index
1
2004
2269
0.010
Why?
Infant, Newborn
1
2001
5769
0.010
Why?
Del Chiaro's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)